#United States #Burlington #Heart Failure #BrioHealth #BrioVAD

BrioHealth Celebrates 100th BrioVAD System Implant

On March 17, 2026, BrioHealth Solutions announced a significant achievement in the medical field with the successful implantation of its 100th BrioVAD System. The BrioVAD (Ventricular Assist Device) is an investigational device aimed at improving the lives of patients suffering from advanced heart failure. This milestone represents not just a numerical achievement but a beacon of hope for many patients who rely on innovative technology for their survival and quality of life.

The BrioVAD System is designed with the latest advancements in mechanical circulatory support, focusing on performance, reliability, and patient-centered care. From its inception, the company has prioritized comprehensive clinical training and robust technical support, ensuring that healthcare providers are well-equipped to implement the device effectively. Moreover, BrioHealth places a strong emphasis on building partnerships with hospitals and optimizing program development to enhance support for patients using the VAD.

Dr. Chen Chen, Ph.D., CEO of BrioHealth Solutions, expressed profound pride in reaching this milestone, stating, “This accomplishment underscores our commitment to advancing the VAD field in collaboration with our clinical partners.” He further emphasized that the journey toward the 100th implant illustrates the dedication of both clinicians and participating patients, setting a promising precedent for future advancements in this area of medicine.

Since launching the program in November 2024, BrioHealth has been conducting clinical trials across 34 locations as part of the INNOVATE Trial. This trial aims to assess the effectiveness of the BrioVAD System in providing durable and sustainable support for patients experiencing severe heart conditions. As stated by Dr. Francis D. Pagani, M.D., Ph.D., a key investigator involved in the study, reaching the 100th implant signifies a pivotal advancement in the realm of cardiac health, and it brings hope to patients who previously had limited treatment options.

The expansion of clinical investigations for the BrioVAD System continues across esteemed cardiac centers in the United States, indicating a positive trajectory toward eventual commercial approval. BrioHealth Solutions is steadfast in its mission to not only introduce cutting-edge medical technology but also to collaborate with healthcare providers worldwide, aiming to extend and enhance the lives of patients afflicted by heart diseases.

This milestone not only marks a significant achievement for BrioHealth but also represents a collective commitment to providing better healthcare solutions for those battling heart failure. As the journey continues, the dedication to improving patient outcomes remains the core of BrioHealth's operations.

In conclusion, the announcement of the 100th BrioVAD System implant serves as an inspiring testament to the progress made in cardiac care and highlights the essential role of innovative technology in transforming patient experiences and outcomes.